Skip to content

The utility of GFAP combined with UCH-L1 in predicting delirium and prognosis in acute type A aortic dissection

The utility of GFAP combined with UCH-L1 in predicting delirium and prognosis in acute type A aortic dissection

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100044813
Enrollment
Unknown
Registered
2021-03-27
Start date
2021-04-05
Completion date
Unknown
Last updated
2021-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute type A aortic dissection

Interventions

Elevated brain injury index group:None
Normal brain damage index group:None

Sponsors

Guangdong Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years; 2. Onset of disease <= 2 weeks; 3. Type A aortic dissection confirmed by CT angiography; 4. Willingness to receive surgery.

Exclusion criteria

Exclusion criteria: 1. Emorrhage/ischemic stroke or other intracranial lesions; 2. With history of brain tumor or other malignant tumors; 3. With brain infection or traumatic brain injury; 4. With neurodegenerative disease, demyelinating disease, Parkinson disease, Alzheimer disease or epilepsy; 5. With connective tissue diseases with nerve system involvement; 6. With pulmonary encephalopathy or hepatic encephalopathy; 7. Recent (= 6 months) oral/intravenous use of corticosteroids; 8. Pregnancy.

Design outcomes

Primary

MeasureTime frame
Glial fibrillary acidic protein (GFAP);Ubiquitin carboxy-terminal hydrolase L1(UCH-L1);

Secondary

MeasureTime frame
In-hospital mortality;Incidence of perioperative cerebral vascular events;Incidence of delirium;Postoperative 30-days all cause mortality;

Countries

China

Contacts

Public ContactLi Xin

Guangdong Provincial People's Hospital

xlidoct@qq.com+86 18902233721

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026